The ministry indicated that its decision was “in line with the U.S. Food and Drug Administration’s (FDA) recommendation to restrict vaccine use due to worrying complications, including blood clots,” explaining that it decided to take the measure. this. ” in the context of his desire to follow the successive development of vaccines against Corona virus.
He added: “The National Pharmacovigilance Center has not received any notification of serious side effects of the Johnson & Johnson vaccine, particularly blood clots.”
He noted that “the Pfizer-Biontech (American-German) vaccine is the most widely used type of vaccine in Tunisia, and the National Coronavirus Vaccination Committee continues to monitor all developments in the field of vaccination against virus nationally and globally. levels. ”
For its part, Tunisian Health Minister Ali Merabet said in a statement broadcast on Radio Mosaique that “since Tunisia received the global vaccination notice at Johnson & Johnson, the ministry has decided to withdraw some batch of this vaccine in accordance with the decision. of the World Health Organization and in the interest of maintaining the health of the Tunisian citizen.
On May 3, the number of people who completed coronavirus vaccination (first and second doses); 6 million 367 thousand 441 Tunisians (out of 11 million 700 thousand people).
Source: Al-Akhbar
